Workplace Discrimination Experiences of Americans With Alcohol Use Disorders and Americans With Drug Use Disorders: A Comparative Analysis

2020 ◽  
pp. 003435522097026
Author(s):  
Mykal Leslie ◽  
Cynthia J. Osborn ◽  
Phillip Rumrill ◽  
Brian McMahon
Keyword(s):  
Alcohol Use ◽  
Drug Use ◽  
Title I ◽  
Equal Employment Opportunity Commission ◽  
Alcohol Use Disorders ◽  
Workplace Discrimination ◽  
Ex Post ◽  
Drug Use Disorders ◽  
Time Period ◽  
Ex Post Facto

The purpose of this study was to investigate the patterns in allegations of workplace discrimination by individuals with alcohol use disorders (AUDs) relative to those with other drug use disorders (DUD). The goal of the research was to describe the uniqueness of workplace discrimination, both actual and perceived, that has occurred against individuals with AUD when compared to those with DUD through analysis of the U.S. Equal Employment Opportunity Commission (EEOC) Integrated Mission System (IMS) database. An ex post facto, causal comparative quantitative design was used to examine Americans with Disabilities Act Amendments Act (ADAAA) Title I complaints received by the EEOC from individuals with AUD ( n = 2,123) from 2009 through 2016 in comparison to ADAAA Title I complaints received from individuals with DUD ( n = 1,472) over the same time period. Results revealed statistically significant differences in the patterns of issues alleged by the two groups. The AUD charging parties (individuals who filed the complaints) were, on average, significantly older and involved fewer African Americans than did the DUD comparison group. Individuals with AUD were significantly less likely than the DUD group to achieve merit closures when investigations were completed. This means that the DUD group’s investigations were more often closed as favorable to the charging party. Implications for rehabilitation practice and further research are discussed.

Workplace Discrimination Involving Charging Parties With Substance Use Disorders Under Title I of the Americans With Disabilities Act

2019 ◽  
Vol 50 (1) ◽  
pp. 7-23 ◽  
Author(s):  
Mykal Leslie ◽  
Steve J. Rainey ◽  
Martin Jencius ◽  
Phillip D. Rumrill ◽  
Brian T. McMahon
Keyword(s):  
Substance Use ◽  
Title I ◽  
Substance Use Disorders ◽  
Americans With Disabilities Act ◽  
Comparison Group ◽  
Equal Employment Opportunity Commission ◽  
Workplace Discrimination ◽  
Ex Post ◽  
Ex Post Facto ◽  
Quantitative Design

The goal of this research was to describe allegations of discrimination, both actual and perceived, that were filed by individuals with substance use disorders (SUDs) in comparison to a group of individuals with other physical disabilities (GENDIS) through analysis of the U.S. Equal Employment Opportunity Commission (EEOC) Integrated Mission System (IMS) database. An ex post facto, causal comparative quantitative design was used to examine Americans with Disabilities Act (ADA) Title I allegations received by the EEOC from charging parties with SUD from 1992 through 2011 (n= 8,432) in comparison to the GENDIS group over the same timeframe (n= 82,618). Results revealed statistically significant differences in the patterns of issues alleged by the two groups. In addition, compared to the GENDIS comparison group, the SUD group was significantly younger, had a significantly higher proportion of males, had proportionally more individuals who identified as Caucasian and as Other, and had proportionally fewer individuals who identified as Hispanic/Mexican and Asian. Charging parties with SUD were significantly less likely than the GENDIS group to have their allegations result in a merit-based case resolution. Implications for rehabilitation practice and further research are discussed.

Alcohol- and Drug-Use Disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing

2000 ◽  
Vol 34 (2) ◽  
pp. 206-213 ◽  
Author(s):  
Maree Teesson ◽  
Wayne Hall ◽  
Michael Lynskey ◽  
Louisa Degenhardt
Keyword(s):  
Public Health ◽  
Mental Health ◽  
Alcohol Use ◽  
Drug Use ◽  
Alcohol Use Disorders ◽  
Treatment Seeking ◽  
Alcohol And Drug Use ◽  
Health And Wellbeing ◽  
Drug Use Disorders ◽  
Icd 10

Objective: This study reports the prevalence and correlates of ICD-10 alcohol- and drug-use disorders in the National Survey of Mental Health and Wellbeing (NSMHWB) and discusses their implications for treatment. Method: The NSMHWB was a nationally representative household survey of 10 641 Australian adults that assessed participants for symptoms of the most prevalent ICD-10 and DSM-IV mental disorders, including alcohol- and drug-use disorders. Results: In the past 12 months 6.5%% of Australian adults met criteria for an ICD-10 alcohol-use disorder and 2.2%% had another ICD-10 drug-use disorder. Men were at higher risk than women of developing alcohol- and drug-use disorders and the prevalence of both disorders decreased with increasing age. There were high rates of comorbidity between alcohol- and other drug-use disorders and mental disorders and low rates of treatment seeking. Conclusions: Alcohol-use disorders are a major mental health and public health issue in Australia. Drug-use disorders are less common than alcohol-use disorders, but still affect a substantial minority of Australian adults. Treatment seeking among persons with alcohol- and other drug-use disorders is low. A range of public health strategies (including improved specialist treatment services) are needed to reduce the prevalence of these disorders.

scholarly journals Co-occurring psychiatric and drug use disorders among sexual minority men with lifetime alcohol use disorders

2015 ◽  
Vol 151 ◽  
pp. 167-172 ◽  
Author(s):  
Ji Hyun Lee ◽  
Kristi E. Gamarel ◽  
Christopher W. Kahler ◽  
Brandon D.L. Marshall ◽  
Jacob J. van den Berg ◽  
...  
Keyword(s):  
Alcohol Use ◽  
Drug Use ◽  
Sexual Minority ◽  
Alcohol Use Disorders ◽  
Sexual Minority Men ◽  
Drug Use Disorders ◽  
Minority Men

scholarly journals Alcohol and drug use disorders in patients with cancer and caregivers: effects on caregiver burden

2020 ◽  
Vol 10 (2) ◽  
pp. 242-247
Author(s):  
Kath Webber ◽  
Andrew Neil Davies ◽  
Charlotte Leach ◽  
Anna Bradley
Keyword(s):  
Drug Abuse ◽  
Alcohol Use ◽  
Drug Use ◽  
Caregiver Burden ◽  
Alcohol Use Disorders ◽  
Alcohol And Drug Use ◽  
Patients With Cancer ◽  
Drug Use Disorders ◽  
Drug Abuse Screening Test ◽  
Identification Tool

BackgroundThe estimated prevalence of alcohol use disorders in patients with advanced cancer is reported as 4%–38%. There are limited data regarding alcohol and drug use disorders in caregivers of patients with cancer and the effects on other issues.AimTo establish the prevalence of alcohol and drug use disorders in a large cohort of patients with advanced cancer and their caregivers.To evaluate the relationship between alcohol and drug use disorders and patient symptoms and caregiver burden.DesignThe patient with cancer and caregiver completed the Alcohol Use Disorders Identification Tool, CAGE questionnaire and Drug Abuse Screening Test. The patient completed the Memorial Symptom Assessment Scale–Short Form, and the caregiver completed the Zarit Burden Questionnaire.Statistical analysis compared cases and non-cases of alcohol and drug use disorders with symptom and burden score.Setting/participantsPatients with cancer, and their caregivers, were recruited from 11 UK sites, 6 hospices and 5 hospitals.ResultsFive hundred and seven patients and their caregivers were recruited. Twenty-seven patients (5%) and 44 caregivers (9%) screened positively for alcohol use disorders on the Alcohol Use Disorders Identification Tool. Thirty patients (6%), and 16 caregivers (3%), screened positively for drug abuse problems on the Drug Abuse Screening Test.There was a significantly higher carer burden score in caregivers screening positively for alcohol and drug abuse problems.ConclusionsThe prevalence of alcohol use disorders in patients with cancer and caregivers was lower than reported in previous studies. Caregiver burden scores were significantly higher in carers screening positively for alcohol and drug use disorders.Trial registration numberTrial registered National Institute for Health Research Clinical Research Network Portfolio (CPMS ID 30723) IRAS ID 198753.

Sign in / Sign up

Export Citation Format

Share Document